Bookrunner Wells Fargo and co-managers Roth Capital and Griffin assist
By Devika Patel
Knoxville, Tenn., July 22 – Fibrocell Science, Inc. said it priced a $15.08 million public offering of stock with a $2.32 million greenshoe. The offering was announced Tuesday.
The company will sell 2.6 million common shares at $5.80 per share. The price per share reflects a 0.86% discount to the July 21 closing share price of $5.85.
Wells Fargo Securities, LLC is the bookrunner.
Settlement is expected July 27.
Proceeds will be used for clinical and preclinical development and general corporate purposes.
Fibrocell is a biotechnology company based in Exton, Pa.
| Issuer: | Fibrocell Science, Inc.
|
| Issue: | Common stock
|
| Amount: | $15.08 million
|
| Greenshoe: | $2.32 million, or 400,000 shares
|
| Shares: | 2.6 million
|
| Price: | $5.80
|
| Warrants: | No
|
| Bookrunner: | Wells Fargo Securities, LLC
|
| Co-managers: | Roth Capital Partners and Griffin Securities
|
| Announcement date: | July 21
|
| Pricing date: | July 22
|
| Settlement date: | July 27
|
| Stock symbol: | Nasdaq: FCSC
|
| Stock price: | $5.85 at close July 21
|
| Market capitalization: | $262.98 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
